|
Delayed
Nasdaq Stockholm
13:09:40 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.730 SEK | -1.93% |
|
-1.70% | -12.18% |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 15/04/21 | 08/04/22 | 29/04/24 | 29/04/24 | 25/04/25 | 29/04/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 08/06/2026 | Ex-dividend date - 0.97854 SEK | 08:00 |
Upcoming Events: IRLAB Therapeutics AB
| 13/11/2026 | Earnings release | Q3 2026 | |
| 24/02/2027 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.6% | 0.67% | 33.02x | 20.95x | 11.99x | |
| 1.98% | 2.08% | 29.7x | - | - | |
| 2.64% | 2.77% | 33.18x | -364.18x | 7.69x | |
| 2.88% | 2.94% | 19.36x | 6.96x | 4.61x | |
| 2.71% | 2.82% | 22.91x | 6.45x | 5.89x | |
| 2.06% | 2.2% | 20.82x | 4.65x | 4.27x | |
| 2.3% | 2.43% | 27.71x | 20.93x | 7.15x | |
| 3.82% | 3.83% | 13.18x | 5.56x | 4.74x | |
| 2.2% | 2.27% | -45.81x | 10.2x | 6.6x | |
| Average | 2.35% | 2.45% | 17.12x | -36.06x | 6.62x | |
| Weighted average by Cap. | 1.96% | 2.05% | 24.07x | -43.78x | 8.04x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
